TipRanks
Advertisement
Advertisement

CELC Stock Latest News

Celcuity initiated with an Overweight at JPMorgan
The FlyCelcuity initiated with an Overweight at JPMorgan
9d ago
CELC
Celcuity Files sNDA to Expand REVTORPYK Breast Cancer Use
PremiumCompany Announcements
Celcuity Files sNDA to Expand REVTORPYK Breast Cancer Use
1M ago
8K
CELC
Celcuity submits Revtorpyk sNDA to the FDA
PremiumThe Fly
Celcuity submits Revtorpyk sNDA to the FDA
1M ago
CELC
Celcuity Inc. Earnings Call: Revtopik Launch Set Stage
PremiumCompany Announcements
Celcuity Inc. Earnings Call: Revtopik Launch Set Stage
1M ago
CELC
Celcuity price target raised to $175 from $165 at Guggenheim
PremiumThe Fly
Celcuity price target raised to $175 from $165 at Guggenheim
1M ago
CELC
Celcuity Initiation: Launch Timing Shift Seen as Low Risk, Buy Rating Reiterated on Strong Launch Readiness and Demand Outlook
PremiumRatingsCelcuity Initiation: Launch Timing Shift Seen as Low Risk, Buy Rating Reiterated on Strong Launch Readiness and Demand Outlook
1M ago
CELC
Celcuity options imply 6.6% move in share price post-earnings
Premium
The Fly
Celcuity options imply 6.6% move in share price post-earnings
1M ago
CELC
Celcuity reports Q2 EPS ($1.07), consensus ($1.16)
Premium
The Fly
Celcuity reports Q2 EPS ($1.07), consensus ($1.16)
1M ago
CELC
Celcuity price target lowered to $150 from $175 at Stifel
PremiumThe Fly
Celcuity price target lowered to $150 from $175 at Stifel
1M ago
CELC
Celcuity price target lowered to $140 from $157 at Needham
PremiumThe Fly
Celcuity price target lowered to $140 from $157 at Needham
1M ago
CELC
Unchanged $165 Target as Gedatolisib’s Strong Clinical Profile and FDA Approval Support Buy Rating
PremiumRatings
Unchanged $165 Target as Gedatolisib’s Strong Clinical Profile and FDA Approval Support Buy Rating
1M ago
CELC
Price Target Trimmed to $140 as Revtorpyk Launch and Gedatolisib Breast Cancer Opportunity Support Buy Rating
PremiumRatings
Price Target Trimmed to $140 as Revtorpyk Launch and Gedatolisib Breast Cancer Opportunity Support Buy Rating
1M ago
CELC
CELC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsCELC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
CELC
Celcuity announces NCCN recommendation for Revtorpyk combination
Premium
The Fly
Celcuity announces NCCN recommendation for Revtorpyk combination
2M ago
CELC
Short Report: Bears book profits in Celcuity
Premium
The Fly
Short Report: Bears book profits in Celcuity
2M ago
ARRY
BOBS
Celcuity falls -19.7%
PremiumThe Fly
Celcuity falls -19.7%
2M ago
CELC
Celcuity: Buy Rating Reaffirmed on Gedatolisib’s Multi-Billion-Dollar Potential, $165 Price Target Unchanged
PremiumRatings
Celcuity: Buy Rating Reaffirmed on Gedatolisib’s Multi-Billion-Dollar Potential, $165 Price Target Unchanged
2M ago
CELC
Celcuity falls -12.6%
PremiumThe Fly
Celcuity falls -12.6%
2M ago
CELC
Celcuity price target raised to $178 from $171 at Craig-Hallum
PremiumThe Fly
Celcuity price target raised to $178 from $171 at Craig-Hallum
2M ago
CELC
Celcuity price target raised to $155 from $145 at H.C. Wainwright
PremiumThe FlyCelcuity price target raised to $155 from $145 at H.C. Wainwright
2M ago
CELC
Celcuity price target raised to $177 from $160 at Citizens
Premium
The Fly
Celcuity price target raised to $177 from $160 at Citizens
2M ago
CELC
Celcuity announces FDA approval of Revtorpyk
Premium
The Fly
Celcuity announces FDA approval of Revtorpyk
2M ago
CELC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >